Novartis commits $1.1B upfront to take Myricx Bio and its next-gen ADC platform

Mohit Rawat, Myricx CEO July 6, 2026 06:46 AM EDT DealsR&D No­var­tis com­mits $1.1B up­front to take Myricx Bio and its next-gen ADC plat­form Ayisha Sharma News Reporter No­var­tis said Mon­day it will be spend­ing $1.1 bil­lion up­front to buy Myricx Bio, which has an ADC pay­load plat­form that could of­fer an edge … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER